BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2824087)

  • 1. Differential regulation of c-Ha-ras and c-Ki-ras gene expression in rat mammary gland.
    Nieto A; Qasba PK; Nakhasi HL; Dhar R
    Carcinogenesis; 1987 Dec; 8(12):1955-8. PubMed ID: 2824087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
    Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E
    Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
    Chiodino C; Jones RF; Ethier SP
    Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic rats.
    Hamaguchi T; Matsuoka Y; Kawaguchi H; Fukamachi K; Takasuka N; Ueda S; Shimizu K; Ohki M; Kusunoki M; Sakakura T; Yoshida H; Tsuda H
    Breast Cancer Res Treat; 2004 Jan; 83(1):43-56. PubMed ID: 14997054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.
    Russo J; Russo IH
    Am J Pathol; 1980 Aug; 100(2):497-512. PubMed ID: 6773421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nuclear proteins from DMBA-induced mammary tumors and lactating mammary glands by polyacrylamide gel electrophoresis.
    Dinh BL; Bourget L
    Breast Cancer Res Treat; 1985; 5(1):37-46. PubMed ID: 2579694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation and expression of rat kappa-casein gene in normal and neoplastic rat mammary gland.
    Thompson MD; Nakhasi HL
    Cancer Res; 1985 Mar; 45(3):1291-5. PubMed ID: 3971374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on four cellular proto-oncogenes and their expression in PCC4 embryonal carcinoma cells: amplification of c-Ki-ras oncogene.
    Vilette D; Emanoil-Ravier R; Tobaly J; Peries J
    Biochem Biophys Res Commun; 1985 Apr; 128(2):513-9. PubMed ID: 2986619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
    Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M
    Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental stages and energy restriction affect cellular oncogene expression in tissues of female rats.
    Baik M; Choi CB; Keller WL; Park CS
    J Nutr; 1992 Aug; 122(8):1614-9. PubMed ID: 1640254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonuclease H activity in rat mammary gland during the lactation cycle and in R3230AC mammary adenocarcinoma.
    Orloski JM; Fritz PJ; Liu DK
    Biochim Biophys Acta; 1980 Sep; 632(1):1-10. PubMed ID: 6158342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin expression in mammary gland development and tumorigenesis.
    Rittling SR; Novick KE
    Cell Growth Differ; 1997 Oct; 8(10):1061-9. PubMed ID: 9342184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
    Kumar R; Medina D; Sukumar S
    Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
    Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
    Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis.
    Yaswen P; Goyette M; Shank PR; Fausto N
    Mol Cell Biol; 1985 Apr; 5(4):780-6. PubMed ID: 2581126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harvey-ras mediated neoplastic development in the mouse mammary gland.
    Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
    Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
    Haag JD; Hsu LC; Newton MA; Gould MN
    Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.